<DOC>
	<DOC>NCT02719431</DOC>
	<brief_summary>The purpose of this study is to assess the effects of K-877 on the pharmacodynamics and the pharmacokinetics of warfarin in healthy adults volunteers.</brief_summary>
	<brief_title>Drug-Drug Interaction Study to Assess the Effects of Multiple-Dose Administration of K-877 on the Pharmacodynamics and the Pharmacokinetics of Multiple-Dose Administration of Warfarin in Healthy Adult Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Warfarin</mesh_term>
	<criteria>Subject provides written informed consent before any study specific evaluation is performed. Subject is a healthy adult male or female volunteer between the ages of 18 and 45 years, inclusive. Subject has a body mass index of 18 to 30 kg/mÂ², inclusive. Subject has clinically relevant abnormalities in the screening or check in assessments. Subject has clinically significant outofrange PT, INR, activated partial thromboplastin time, fibrinogen, protein C, or protein S. Subject has abnormal prolongation of skin bleeding time at Screening.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>